Kiniksa Pharmaceuticals, Ltd.

Historical 13F Holders

Symbol
KNSA
CUSIP
G52694109
All holders as of
Q2 2026
Type
Equity
Class
ORD SHS CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for G52694109 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
14.8% 5/6/2026
Event 3/31/2026
Rubric Capital Management LP 13G/A
7.4% 2/13/2026
Event 12/31/2025
Baker Bros. Advisors LP 13D/A
7.0% 5/26/2026
Event 5/21/2026
BlackRock, Inc. 13G 5.5% 7/29/2026
Event 6/30/2026
Tang Capital Management LLC 13G
5.2% 4/4/2025
Event 3/28/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Fairmount Funds Management LLC 13G/A
0% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 8 51.2 k $3.82 M
2026 Q2 279 49.7 M $3.04 B
2026 Q1 235 45.4 M $2.18 B
2025 Q4 232 43.0 M $1.77 B
2025 Q3 212 41.0 M $1.59 B
2025 Q2 197 40.8 M $1.13 B
2025 Q1 184 40.0 M $888 M
2024 Q4 166 39.0 M $771 M
2024 Q3 185 39.7 M $993 M
2024 Q2 135 37.2 M $695 M